Skip to content
AnzuPartners
  • About
  • Solutions
    • Debt and Revenue-Based Investments
    • Special Purpose Acquisition Companies (SPACs)
  • Press
  • Resources
    • Newsletter
    • Newsroom
  • Contact
    • Company Questionnaire
  • Team
  • Talent
  • About
  • Solutions
    • Debt and Revenue-Based Investments
    • Special Purpose Acquisition Companies (SPACs)
  • Press
  • Resources
    • Newsletter
    • Newsroom
  • Contact
    • Company Questionnaire
  • Team
  • Talent

6K Awarded Prestigious Department of Energy Grant to Fund $107M UniMelt Plasma Processing Plant for Domestic Battery Material Production

The new plant will demonstrate the ability to domestically produce multiple battery chemistries in the same
factory with the capacity of 3,000 tons per annum (tpa) in 2025 scaling to 10,000 tpa in 2026

BioSkryb Genomics and Cooper Surgical Ink Multi-Year Deal to Accelerate Clinical Discovery and Diagnostics in Women’s Reproductive Health

New partnership brings transformative, high-resolution single-cell genomic technology to the field of preimplantation genetic testing in the pursuit of improved discovery and clinical outcomes.

e-Zinc Works with Silicon Valley Bank and Secures USD $7 Million Venture Debt Facility

The funding will be used to expand production at e-Zinc’s new Mississauga, ON facility and accelerate commercialization efforts

e-Zinc CEO James Larsen Named to Canada’s 2023 Clean50

e-Zinc announced that its CEO James Larsen was named one of Canada’s 2023 Clean50 in the research and development category.

InterVenn Biosciences Co-Founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry

InterVenn Biosciences announced that its co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in chemistry.

InterVenn Biosciences Expands Board of Directors with Dr. Jason Myers and Carol Berry to Support Next Phase of Growth

InterVenn Biosciences announced the appointment of Jason Myers, Ph.D., and Carol Berry to the company’s Board of Directors.

Excision BioTherapeutics Awarded California Institute for Regenerative Medicine (CIRM) Grant to Support Ongoing Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV

CIRM Grant of $6.85 million supports the first-in-human clinical study evaluating the safety and efficacy of EBT-101 in participants people living with HIV

Xendee Integrates UtilityAPI for Easier, Faster and More Precise Energy Load Modeling

The integration maximizes the efficiency of downloading past building load data directly from the utility, which gives engineers a more accurate view of past usage and peak requirements of their project.

Niron Magnetics Expands Management Team with Three Key Technology and Operations Hires

Experts in materials science, engineering, and operations will help Niron commercialize the world’s first high performance rare-earth free permanent magnets

Anzu Partners Welcomes Donald Rosenberg as Venture Partner

Rosenberg will work with portfolio companies as they develop their intellectual property strategies and more broadly support the next generation of transformative technology companies.

← Previous
Next →

QUICK LINKS

About

Portfolio

Team

RESOURCES

Press Releases

Newsroom

Newsletter

GET IN TOUCH

Company Questionnaire

Talent

Contact Us

Investor Portal

CONNECT WITH US

Twitter Linkedin

© 2025 Anzu Partners

Privacy Policy

Supplier Code of Business Conduct

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT